What To Expect For Healthcare Sector In Budget? Here's A List
Pharmaceutical companies in the country, the largest provider of generic drugs globally, have faced several challenges in recent times. Where on one hand currency fluctuations have limited the profitability for some companies, regulatory restrictions and pending approvals have impacted the others in the past one year. In a boost to the industry, the government has allowed FDI or foreign direct investment up to 100 per cent under the automatic route for manufacturing of medical devices under certain conditions. But are there any other steps needed to boost the pharma sector? With the government set to present its Interim Budget on February 1, all eyes are on any announcements for the pharma sector.
Here are some of the expectations in the healthcare sector listed by industry body Ficci:
Tax Exemption on preventive health check-ups
Every year, roughly 5.8 million persons in the country succumb to heart and lung diseases, stroke, cancer and diabetes. Non-communicable Diseases (NCDs) like diabetes, heart diseases and respiratory diseases are expected to comprise more than 75 per cent of the country's disease burden by 2025. Preventive health check-ups can help in early diagnosis and timely treatment of NCDs, hence lowering complications, mortality and burden on secondary and tertiary care facilities. It is recommended that tax exemption on preventive health check-up should be raised from the current Rs 5,000 per person to Rs 20,000 under section 80-D of Income Tax Act 1961.
Further, given the rising advent of lifestyle diseases in the country and the need to prevent loss of productivity, it is imperative that employers get a separate annual deduction of up to Rs 10,000 per employee, towards expenses incurred for sponsoring the health check expenses of their employees.
Medical reimbursement exemption limit for salaried employees to be set at Rs 1,00,000 per annum The annual Medical reimbursement limit set at a sum of Rs 15,000 per annum under Section 17(2) of the Income Tax Act which was fixed in April 1999, has been merged along with conveyance allowance into a composite standard deduction limit of Rs 40,000.
Given the significant rise in cost inflation index in general (70 per cent over the last 5 years) and medical inflation in particular, the medical reimbursement deduction needs to be re-introduced and the annual limit needs to be enhanced to not less than Rs 100,000 per annum.
Restoration of weighted deduction under Section 35AD
Currently, a weighted deduction under section 35AD of the Act in respect of the capital expenditure (other than land/ goodwill/ financial instrument) is available to a taxpayer engaged in building and operating a hospital with at least hundred beds which has commenced its operations on or after April 1, 2012. However, with effect from April 1, 2017, deduction under section 35AD of the Act is restricted to 100 per cent of the expenditure only. A sudden withdrawal from April 01, 2017 has led to a significant negative impact on the initiatives that have already commenced on these fronts.
Given the urgent need to add bed capacity in the sector, the 150 per cent weighted deduction scheme should be allowed to continue for the healthcare sector for an additional 10 years at least.
Simplification of the tax regime in respect of real estate investment trusts (REITs)/business trust
Under the revised scheme announced in the last Union Budget, there would be no capital gains tax exposure for the sponsor at the time of the listing of the units or subsequent divestment (if securities transaction tax has been paid). Further the REIT/business trust would not suffer tax on the rental income distributed, though individual investors in the REIT would be liable to pay tax on the income distribution by the REIT. Simplification of the tax regime would accelerate growth and ensure scale, speed and skill sets for setting up more hospitals and help attract more FDI inflows. It is recommended that there should be no capital gains tax incidence at the time of setting up of a REIT/business trust as well for individual investors on the income distribution by the REIT/Business Trust.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.